Drawing for ADRISTES

USPTO serial 78389924

ADRISTES

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
BELLO, ZACK
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADRISTES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jane Ungaro

JANE UNGARO PFIZER INC201 TABOR RDLEGAL - TRADEMARKS - 56/2/SMORRIS PLAINS, NJ 7950

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, sleep disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations, preparations for the treatment of HIV and AIDSACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2004ABN1ABANDONMENT - EXPRESS MAILED—
Sep 10, 2004DOCKASSIGNED TO EXAMINER—
May 28, 2004MAILPAPER RECEIVED—
Apr 2, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance